BioCentury
ARTICLE | Clinical News

Breast Cancer Index regulatory update

July 28, 2014 7:00 AM UTC

bioMerieux’s bioTheranostics Inc. company said the New York State Department of Health approved the company’s Breast Cancer Index (BCI) to determine the risk of early and late recurrence and benefit f...